Andersen J R, Schroeder E, Lebech P E
Acta Endocrinol (Copenh). 1980 Dec;95(4):433-7. doi: 10.1530/acta.0.0950433.
25 women aged 53--78 years with at least two years menopause were divided in three groups receiving one of the following oral treatments for three weeks: 2 mg oestradiol-17 beta plus 1 mg oestriol, 4 mg oestradiol-17 beta plus 2 mg oestriol or 50 micrograms ethinyloestradiol daily. Blood samples were collected before, during and after the treatment and the effect on the serum concentration of prolactin, oestradiol-17 beta, follicle-stimulating hormone and luteinizing hormonee was evaluated. During treatment with natural human oestrogens serum oestradiol-17 beta levels were significantly higher than before treatment. The serum concentration of prolactin was unchanged in patients receiving 2 mg oestradiol-17 beta plus 1 mg oestriol but increased in patients receiving 4 mg oestradiol-17 beta plus 2 mg oestriol or 50 micrograms ethinyl-oestradiol, thus indicating dose-dependence for natural human oestrogens. However, the increase was moderate, and these higher levels were not significantly different from levels of prolactin in serum found in 16 younger women. Concentrations of follicle-stimulating hormone and luteinizing hormon were depressed during treatment, the former to significantly lower levels when higher doses of oestrogens were used.
25名年龄在53至78岁之间、绝经至少两年的女性被分为三组,接受以下三种口服治疗中的一种,为期三周:每日服用2毫克17β - 雌二醇加1毫克雌三醇、4毫克17β - 雌二醇加2毫克雌三醇或50微克乙炔雌二醇。在治疗前、治疗期间和治疗后采集血样,并评估其对催乳素、17β - 雌二醇、促卵泡激素和促黄体生成素血清浓度的影响。在用天然人雌激素治疗期间,血清17β - 雌二醇水平显著高于治疗前。接受2毫克17β - 雌二醇加1毫克雌三醇治疗的患者催乳素血清浓度未发生变化,但接受4毫克17β - 雌二醇加2毫克雌三醇或50微克乙炔雌二醇治疗的患者催乳素血清浓度升高,这表明天然人雌激素存在剂量依赖性。然而,这种升高幅度适中,且这些较高水平与16名年轻女性血清中的催乳素水平无显著差异。治疗期间促卵泡激素和促黄体生成素的浓度降低,使用较高剂量雌激素时,前者降至显著更低水平。